Phio Pharmaceuticals Corp (PHIO) Company Profile & Statistics

Phio Pharmaceuticals Corp
PHIO
(Nasdaq - US)
N/A
0.68
-0.03 (-3.70%)
in:usd•As of: Apr 26, 2024 12:08 UTC -4
Open
0.68
High
0.68
Low
0.66

About Phio Pharmaceuticals Corp

CEO

Robert J. Bitterman

Auditor

BDO USA, P.C.

Sector

health technology

Employees

Headquarters

11 apex drive, suite 300a

marlborough, ma 01752, united states

Website

https://phiopharma.com

Industry

biotechnology

Share Holders

Company Overview

Phio Pharmaceuticals Corp is focused on developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi therapeutic platform. The Company's pipeline consists of RXI-762 and RXI-804 which are in clinical stage. Phio Pharmaceuticals Corp, formerly known as RXi Pharmaceuticals Corporation, is based in Marlborough, United States.

Phio Pharmaceuticals Corp Statistics

Valuation Measures

Market Capitalization ²	3.12M
Enterprise Value	-5.37M
Enterprise Value/EBITDA (ttm)	0.50
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.33
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-134.66%
Return on Invested Capital (ttm)	-138.06%
Return on Assets (ttm)	-105.86%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-10.77M
Net Income Avi to Common (ttm)	-10.83M
Diluted EPS (ttm)	-5.93

Share Statistics

Beta (5Y Monthly)	1.44
52-Week Change	-82.29%
S&P500 52-Week Change	25.74%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	4.59M
Dividend Yield	0.00%
Float ⁴	4.56M
% Held by Insiders	0.77%
% Held by Institutions	57.31%

Balance Sheet

Total Cash (mrq)	8.49M
Total Cash Per Share (mrq)	1.85
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	5.71%
Quick Ratio (mrq)	5.71%
Book Value Per Share (mrq)	2.06

Cash Flow

Operating Cash Flow Per Share (ytd)	-5.16
Free Cash Flow (ytd)	-10.75M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Phio Pharmaceuticals Corp

Trade With A Regulated Broker